Parkwalk manage a series of EIS Funds that invest in innovative, high-growth companies with strong IP backing their commercialisation. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at 30 June 2018 the combined group has net assets of £1.49bn, third-party funds under management of more than £200m and currently has a market capitalisation of c.£1.37bn.
Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun-out of UK universities. Their funds seek to generate capital gains for investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK government to stimulate innovative emerging technology companies and thereby help drive economic growth.
Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow.
Parkwalk EIS Funds have invested in over 80 companies, which have raised in excess of £1bn of funding between them since 2010 and over 800 patents protect their technology and processes. The fund has had a strong track record and Parkwalk are one of the only EIS funds to publish their performance monthly on their website, available here: http://parkwalkadvisors.com/pw_performance/
Parkwalk has won multiple awards, including the EIS Association ‘Best Fund Manager‘ 2017; Investment Week ‘Best EIS Generalist‘ award 2016/17 and ‘Best EIS Fund‘ 2015/16; the EIS Association ‘Best Fund Manager’ 2016, ‘Best Exit of 2016‘ and ‘Best Exit of 2014‘ awards and has been named by Crunchbase as one of the UK’s top 10 most active technology investors annually since 2014.
Parkwalk also manage a series of earlier-stage EIS Funds in conjunction with some of the world’s most highly regarded research institutes, including the University of Cambridge Enterprise Funds, the University of Oxford Innovation Funds, and the University of Bristol Enterprise Funds; these funds allow our investors access to some of the world’s highest calibre discoveries and IP.